# Clinical Study to Test a New Drug to Treat Major Depression

> **NCT00976560** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 128 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** GW856553
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00976560
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-25
- **Primary completion:** 2010-07-07
- **Final completion:** 2010-07-07
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976560, "Clinical Study to Test a New Drug to Treat Major Depression". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00976560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*